SCHEMBL20140932

SCHEMBL20140932

Cc1cc(C)c(N(c2ccccc2C#N)C2CCNCC2)c(C)c1C(=O)N1CCN(c2ncccc2S(N)(=O)=O)CC1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MTOR P42345 3/20 0.56
RPTOR Q8N122 3/20 0.56
MLST8 Q9BVC4 3/20 0.56
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
PARP1 P09874 9/20 0.38
PARP2 Q9UGN5 9/20 0.38
PARP3 Q9Y6F1 9/20 0.38
HDAC2 Q92769 2/20 0.38
RECQL P46063 1/20 0.37
CFTR P13569 1/20 0.37
TNKS O95271 1/20 0.36
PARP6 Q2NL67 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20140981 0.91 MTOR (0.46) MTORRPTORMLST8KDM4EALDH1A1
SCHEMBL20140935 0.91 MTOR (0.53) MTORRPTORMLST8KDM4EALDH1A1
SCHEMBL20141210 0.89 MTOR (0.65) MTORRPTORMLST8KDM4EALDH1A1
SCHEMBL20141035 0.84 MTOR (0.45) MTORRPTORMLST8KDM4E
SCHEMBL20141671 0.80 MTOR (0.44) MTORRPTORMLST8KDM4EALDH1A1
SCHEMBL20142302 0.79 MTOR (0.55) MTORRPTORMLST8KDM4EALDH1A1
SCHEMBL20140929 0.78 MTOR (0.57) MTORRPTORMLST8KDM4EALDH1A1
SCHEMBL20133682 0.77 MTOR (0.82) MTORRPTORMLST8KDM4EALDH1A1
SCHEMBL20140814 0.77 MTOR (0.45) MTORRPTORMLST8ALDH1A1CA12
SCHEMBL20140851 0.76 MTOR (0.44) MTORRPTORMLST8KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538091-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF Navitor Pharmaceuticals, Inc. (US) 2019-09-18 EP disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
US-20160022830-A1 METHODS FOR PREPARING POLYMERIC REAGENTS NEKTAR THERAPEUTICS 2016-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160022830-A1 METHODS FOR PREPARING POLYMERIC REAGENTS PAM, ALKBH3, DNPEP MTOR 3982/4885RPTOR 4542/4885MLST8 3123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.